Advaxis (ADXS) announced that it has received notification from Nasdaq that the company’s common stock will be subject to delisting, as it has failed to regain compliance with the Listing Rule.   Shares of the clinical-stage biotechnology company were down 1.6% in Monday’s early trading session.  (See ADXS stock chart on TipRanks) According to an SEC filing by Advaxis, the company’s shares could be delisted, unless Advaxis requests a hearing with the Nasdaq Hearing Panel. The company confirmed that it will make a timely request for a hearing.
https://www.tipranks.com/news/advaxis-receives-notice-of-delisting-from-nasdaq
Advaxis (NASDAQ:ADXS)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Advaxis Charts.
Advaxis (NASDAQ:ADXS)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Advaxis Charts.